Hellerup, Denmark

Philippe Andres

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Union Therapeutics A/s. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Andres. Retrieved from https://idiyas.com/inventor/philippe-andres-bzmicddl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Philippe Andres in Viral Infection Treatment

Introduction

Philippe Andres is an accomplished inventor based in Hellerup, Denmark. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. With a total of two patents to his name, Andres is recognized for his innovative approaches to healthcare.

Latest Patents

Andres's latest patents focus on niclosamide formulations for treating diseases. One of his notable inventions relates to a method of treating a viral infection caused by or associated with SARS-CoV-2. This method involves administering a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin, through inhalation intraorally and/or intranasally.

Career Highlights

Philippe Andres has established himself as a key figure in the pharmaceutical industry. He works at Union Therapeutics A/S, where he continues to develop innovative solutions for pressing health challenges. His work is characterized by a commitment to improving patient outcomes through scientific advancements.

Collaborations

Andres collaborates with talented professionals in his field, including Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. These partnerships enhance the research and development efforts at Union Therapeutics A/S.

Conclusion

Philippe Andres is a notable inventor whose work in niclosamide formulations represents a significant advancement in the treatment of viral infections. His contributions to the field of medicine are paving the way for innovative therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…